摘要
新型冠状病毒肺炎是一种新发疾病,国家卫生健康委员会和国家医疗保障局根据ICD-10编码规则紧急新增U07.1用于新型冠状病毒肺炎(COVID-19)确诊病例的编码,Z03.800x001用于疑似病例的编码。COVID-19的编码主要分疑似病例、确诊病例和复阳病例3种情况。由于COVID-19暂无特效治疗药物,复阳病例的治疗跟确诊病例一样主要根据患者的具体临床分期情况进行治疗。因此,复阳病例编码根据患者具体情况使用U07.1进行编码。文章根据COVID-19的发病机制、临床表现和ICD-10编码规则分析这3种情况的编码。目前新发疾病编码无法根据主导词查找编码,编码容易造成不确定性。编码员要熟悉编码规则;学习相关临床知识;加强与临床医师沟通,提高编码的准确性。
COVID-19 is an emerging disease.According to the ICD-10 coding rules,the National Health Commission and the National Healthcare Security Administration have urgently added U07.1 for confirmed COVID-19(COVID-19)cases and Z03.800 x001 for suspected cases.Covid-19 is encoded in three categories:suspected cases,confirmed cases and recurrent cases.Since there is no specific drug for COVID-19 treatment,the treatment of patients with reinfection,like confirmed cases,is mainly based on the specific clinical stage of the patient.Therefore,U07.1 is used to encode the case code of multiple positive patients according to their specific conditions.This article analyzes the coding of coVID-19 based on its pathogenesis,clinical manifestations,and ICD-10 coding rules.At present,the coders for newly emerging diseases cannot be found according to the dominant words,which may easily cause uncertainty.Coders should be familiar with coding rules,earn relevant clinical knowledge and strengthen communication with clinicians to improve the accuracy of coding.
作者
梁秀静
Liang Xiujing(Department of Medical Records,The Fourth People's Hospital of Nanning,Nanning 530021,Guangxi Zhuang Autonomous Region,China)
出处
《中国病案》
2020年第11期55-58,共4页
Chinese Medical Record
